BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-494

  1. 1,045 Posts.
    lightbulb Created with Sketch. 269
    Its clear the market is not convinced the active works or managements story. This is much more high risk now but still has a chance of glory.

    will take time though..
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.